Restricted accessResearch articleFirst published online 2002-9
Prolonged Administration over Six Hours of Large Doses of Intravenous Iron Saccharate (500 mg) Prevents Severe Adverse Reactions in Peritoneal Dialysis Patients
AkcicekF., OzkahyaM., CiritM., OkE., UnsalA., TozH.The efficiency of fractionated parenteral iron treatment in CAPD patients.Adv Perit Dial1997; 13: 109–12.
2.
SilverbergJ.S., BlumM., PeerG., KaplanG., IainaA.Intravenous ferric saccharate as an iron supplement in dialysis patients.Nephron1996; 72: 413–17.
3.
VychytilA., Haag–WeberM.Iron status and iron supplementation in peritoneal dialysis patients.Kidney Int Suppl1999; 69: 571–8.
4.
AhsanN., GroffJ.A., WaybillM.A.Efficacy of bolus iron dextran treatment in peritoneal dialysis patients receiving recombinant human erythropoietin.Adv Perit Dial1996; 12: 161–6.
5.
AhsanN.Intravenous infusion of total dose iron is superior to oral iron in treatment of anemia in peritoneal dialysis patients. A single center comparative study.J Am Soc Nephrol1998; 9: 664–8.
6.
MichaelB., CoyneD.W., FishbaneS., FolkertV., LynnR., NissensonA.R.Sodium ferric gluconate complex in haemodialysis patients: Adverse reactions compared to placebo and iron dextran.Kidney Int2002; 61: 1830–9.
7.
PrakashS., WaleleA., DimkovicN., BargmanJ., VasS., OreopoulosD.Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients.Perit Dial Int2001; 21: 290–5.
8.
MacdougallI.C.Intravenous administration of iron in epoetin-treated haemodialysis patients. Which drugs, which regimen?Nephrol Dial Transplant2000; 15: 1743–5.
9.
NKF-DOQI clinical practice guidelines for hemodialysis adequacy.Am J Kidney Dis1997; 30(Suppl 3): 192–236.
